Wellington Biomedical Innovation Master Investors (Cayman) I L.P. - Jul 18, 2024 Form 3 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
10%+ Owner
Signature
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. By: Wellington Management Company LLP, as Investment Adviser /s/ Jennifer C. Boylan, Title: Authorized Person
Stock symbol
ARTV
Transactions as of
Jul 18, 2024
Transactions value $
$0
Form type
3
Date filed
7/18/2024, 08:06 PM
Previous filing
Apr 2, 2024
Next filing
Jul 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ARTV Series B Preferred Stock Jul 18, 2024 Common Stock 145K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B Preferred Stock is convertible into shares of Common Stock of the Issuer on a one-for-one basis without payment of further consideration. Upon the closing of the Issuer's initial public offering, the Series B Preferred Stock will convert into the number of shares of Common Stock of the Issuer shown in column 3. The Series B Preferred Stock has no expiration date.